Detalhes bibliográficos
| Resumo: | BACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice' care for the diagnosis, treatment and prevention of post-COVID-19 lung disease.METHODS: A panel of international experts representing scientific societies, associations and groups active in post-COVID-19 lung disease was identified; 45 completed a Delphi process. A 5-point Likert scale indicated level of agreement with the draft standards. The final version was approved by consensus (with 100% agreement).RESULTS: Four clinical standards were agreed for patients with a previous history of COVID-19: Standard 1, Patients with sequelae not explained by an alternative diagnosis should be evaluated for possible post-COVID-19 lung disease; Standard 2, Patients with lung function impairment, reduced exercise tolerance, reduced quality of life (QoL) or other relevant signs or ongoing symptoms ≥4 weeks after the onset of first symptoms should be evaluated for treatment and pulmonary rehabilitation (PR); Standard 3, The PR programme should be based on feasibility, effectiveness and cost-effectiveness criteria, organised according to local health services and tailored to an individual patient's needs; and Standard 4, Each patient undergoing and completing PR should be evaluated to determine its effectiveness and have access to a counselling/health education session.CONCLUSION: This is the first consensus-based set of clinical standards for the diagnosis, treatment and prevention of post-COVID-19 lung disease. Our aim is to improve patient care and QoL by guiding clinicians, programme managers and public health officers in planning and implementing a PR programme to manage post-COVID-19 lung disease. |
|---|
| Autores principais: | Visca, D. |
|---|
| Outros Autores: | Centis, R.; Pontali, E.; Zampogna, E.; Russell, A. M.; Migliori, G. B.; Andrejak, C.; Aro, M.; Bayram, H.; Berkani, K.; Bruchfeld, J.; Chakaya, J. M.; Chorostowska-Wynimko, J.; Crestani, B.; Dalcolmo, M. P.; D'Ambrosio, L.; Dinh-Xuan, A. T.; Duong-Quy, S.; Fernandes, C.; García-García, J. M.; de Melo Kawassaki, A.; Carrozzi, L.; Martinez-Garcia, M. A.; Martins, P. Carreiro; Carreiro Martins, Pedro; Mirsaeidi, M.; Mohammad, Y.; Naidoo, R. N.; Neuparth, N.; Sese, L.; Silva, D. R.; Solovic, I.; Sooronbaev, T. M.; Spanevello, A.; Sverzellati, N.; Tanno, L.; Tiberi, S.; Vasankari, T.; Vasarmidi, E.; Vitacca, M.; Annesi-Maesano, I. |
|---|
| Assunto: | General Medicine SDG 3 - Good Health and Well-being |
|---|
| Ano: | 2023 |
|---|
| País: | Portugal |
|---|
| Tipo de documento: | artigo |
|---|
| Tipo de acesso: | acesso aberto |
|---|
| Instituição associada: | Universidade Nova de Lisboa |
|---|
| Idioma: | inglês |
|---|
| Origem: | Repositório Institucional da UNL |
|---|